Search

everythinglearnresearchcommunity

for

Search:↓

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.

Alcohol may slightly increase the risk of hair loss, but the link is uncertain.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Trichilemmal carcinoma can spread to the parotid gland and be diagnosed using fine-needle aspiration cytology.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Hair loss in men aged 25-44 may be linked to gum disease.

Aging changes scalp cells, possibly affecting hair health in older women.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Current methods can't accurately predict which long-form answers people prefer; evaluations should consider different answer qualities separately.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

The authors agree they didn't follow the original criteria strictly but found the Ottawa rule effective in all tested patients and suggest it might have wider use.

Platelet-rich plasma is a promising and cost-effective treatment for hair and skin issues in older adults in India.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

The authors concluded that PRP injections were not significantly effective for treating lichen planopilaris and its variants and should not be used as the only treatment.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.